share_log

Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jan 16 00:00
Summary by Moomoo AI
Eli Lilly and Co, a major pharmaceutical company, is set to experience a significant transaction involving its common stock. LILLY ENDOWMENT INC, a key stockholder with a 10% stake, plans to sell 210,000 shares of Eli Lilly's common stock. The sale, with an aggregate market value of approximately $135 million, is scheduled for 01/16/2024. The shares were originally acquired as a gift from the J.K. Lilly Sr. Trust on 02/10/1948, which had been in possession of the securities since 01/21/1937. Over the past three months, LILLY ENDOWMENT INC has sold a total of 225,000 shares of Eli Lilly, generating gross proceeds of nearly $142 million.
Eli Lilly and Co, a major pharmaceutical company, is set to experience a significant transaction involving its common stock. LILLY ENDOWMENT INC, a key stockholder with a 10% stake, plans to sell 210,000 shares of Eli Lilly's common stock. The sale, with an aggregate market value of approximately $135 million, is scheduled for 01/16/2024. The shares were originally acquired as a gift from the J.K. Lilly Sr. Trust on 02/10/1948, which had been in possession of the securities since 01/21/1937. Over the past three months, LILLY ENDOWMENT INC has sold a total of 225,000 shares of Eli Lilly, generating gross proceeds of nearly $142 million.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more